AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pharmaceutical Companies

806.248

-3.677-0.45%

Number of Gainers:9

Number of Losers:14

Number of Flat:22

PE:- -

High:816.991

Open:809.925

Low:806.079

Close:809.925

Loading ...

NZX Midday Sector Update: Distribution Services Soars, Electronic Technology Falls

MT Newswires Live

Australia shares cross 8,500 as oil lifts energy stocks; tech, healthcare shine

Mayne Says Cosette Consultation Period Expires Without Termination Notice; Shares Up 4%

MT Newswires Live

BUZZ-New Zealand's Rua Bioscience surges on legal resolution with Australia's Cann Group

Mayne Pharma Group Ltd - Board Does Not Consider Material Adverse Change

THOMSON REUTERS

Mayne Pharma Group Ltd - Committed to Scheme Completion

THOMSON REUTERS

Mayne Pharma Group Ltd - 10 Business Day Consultation Period Asserted by Cosette in Cosette Notice Has NOW Expired

THOMSON REUTERS

BRIEF-Rua Bioscience Says Co & Cann Reach Resolution In Legal Proceedings

Immuron Ltd-Proposed Issue of Securities - Imc

THOMSON REUTERS

ASX Midday Sector Update: Energy Stocks Rise, Healthcare Struggles

MT Newswires Live

Paradigm Biopharmaceuticals Activates First Australian Site for Phase Three Osteoarthritis Trial

MT Newswires Live

Opthea Limited Trading Halted on ASX and Nasdaq Amid Financial Uncertainty and Ongoing Negotiations

Australian Shares Flat as US-China Trade Tensions Escalate; Brickworks, Soul Pattinson Agree to Merge

MT Newswires Live

Mayne Pharma Group Unit Seeks Over $11.5 Million in Damages in US Court Complaint Against TherapeuticsMD

MT Newswires Live

My top 3 picks in the ASX 20 in June

Opthea Says 'Going Concern' Uncertainty Remains as Talks With Development Funding Agreement Investors Continue

MT Newswires Live

BRIEF-Mayne Pharma Posts Update On US Legal Proceeding With Therapeuticsmd Inc

Mayne Pharma Group Ltd - Files Complaint Against TherapeuticsMD in US Court

THOMSON REUTERS

Mayne Pharma Group Ltd - Seeks Over $11.5 Mln in Damages From Txmd

THOMSON REUTERS

Update on US Legal Proceeding With TherapeuticsMD Inc-Myx.ax

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK7508/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":806.24774,"timestamp":1749189599976,"preClose":809.925,"halted":0,"volume":49882817,"delay":0,"changeRate":-0.00454,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-3.677246,"latestTime":"06-06 16:00:00 AEST","open":809.925,"high":816.99097,"low":806.07916,"amount":127636809,"amplitude":0.013473,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1749513600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1749168000000,1749189600000]],"turnoverRate":0.001585,"increases":8,"decrements":16,"flats":19,"marketCap":126924971440.99219,"floatMarketCap":124496830075.07617},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":816.99097,"amplitude":0.013473,"preClose":809.925,"low":806.07916,"latestPrice":806.24774,"volume":49882817,"delay":0,"open":809.925,"prevYearClose":936.801,"prevWeekClose":825.374,"prevMonthClose":825.374,"prevQuarterClose":815.605,"fiveDayClose":825.374,"twentyDayClose":797.289,"sixtyDayClose":829.898,"secType":"PLATE","market":"AU","turnoverRate":0.001585,"marketCap":126924971440.99219,"floatMarketCap":124496830075.07617,"timestamp":1749189599976,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":9,"down":14,"flat":22},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2540192084","title":"NZX Midday Sector Update: Distribution Services Soars, Electronic Technology Falls","url":"https://stock-news.laohu8.com/highlight/detail?id=2540192084","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540192084?lang=en_us&edition=fundamental","pubTime":"2025-06-04 10:14","pubTimestamp":1749003283,"startTime":"0","endTime":"0","summary":"Distribution services shares gained the most on the New Zealand Exchange, rising nearly 5% by midday Wednesday.Rua Bioscience  shares rose 8% in recent trade after it reached a settlement in its legal proceedings with Cann Group .Meanwhile, electronic technology shares fell nearly 1%.ikeGPS Group  drove the decline, falling 3% in recent trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK8020","BK7084","CAN.AU","NZ50G.NZ","BK7096","NZX.NZ","BK7502","NZ20C.NZ","T10G.NZ","IKE.AU"],"gpt_icon":0},{"id":"2540086411","title":"Australia shares cross 8,500 as oil lifts energy stocks; tech, healthcare shine","url":"https://stock-news.laohu8.com/highlight/detail?id=2540086411","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540086411?lang=en_us&edition=fundamental","pubTime":"2025-06-04 09:07","pubTimestamp":1748999234,"startTime":"0","endTime":"0","summary":"Australia shares cross 8,500 as oil lifts energy stocks; tech, healthcare shine June 4 (Reuters) - Australian shares charged past the key psychological 8,500 mark on Wednesday, led by energy stocks on","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nL3N3S7017:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","LU1078025761.USD","BK7129","BK7083","BK7507","LU0171293334.USD","LU1430597077.USD","SG9999001143.SGD","LU0456854461.SGD","LU0955669360.SGD","BK7142","RIO.UK","CSL.AU","COH.AU","LU0612318385.USD","BK7067","IE00BQJZX424.USD","BK7016","LU0266512127.USD","LU0330918003.SGD","BK7043","BK7503","IE00B3M56506.USD","BK5111","LU1064927863.SGD","LU0011963245.USD","BK7007","BK7511","BK7095","LU0345780950.USD","BOE.AU","LU0505663152.USD","SG9999002521.SGD","LU0345777147.USD","MP1.AU","BHP.AU","BK7501","IE0034235071.USD","STO.AU","LU0630314457.HKD","LU0612318971.USD","IE00BWDBJ516.SGD","FMG.AU","LU0345777659.USD","LU0345781412.USD","LU0788109121.HKD","LU0898667661.SGD","LU1130305938.SGD","LU0831103253.SGD","WTC.AU"],"gpt_icon":0},{"id":"2540085083","title":"Mayne Says Cosette Consultation Period Expires Without Termination Notice; Shares Up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540085083","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540085083?lang=en_us&edition=fundamental","pubTime":"2025-06-04 08:39","pubTimestamp":1748997593,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group  said the consultation period initiated by Cosette Pharmaceuticals under their scheme implementation deed has expired without Cosette issuing a termination notice, according to a Wednesday filing with the Australian bourse.In February, the company said it entered a scheme implementation deed  to be acquired by Cosette via a scheme of arrangement for AU$7.40 per share.On May 17, Cosette issued a notice triggering a 10-day good-faith consultation period under the SID, citing a material adverse change.Mayne Pharma rejected the claim, stating no such change occurred and all relevant disclosures had been made. While Cosette has not terminated the deal, it signaled it may do so if the issue remains unresolved.The company said the expiry of the period does not prevent Cosette from terminating the deal.Mayne also confirmed receipt of a close-out letter from the US Food and Drug Administration, stating that the company has addressed previous regulatory concerns.Shares of the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4006","BK7508","MYX.AU","SID","BK7096"],"gpt_icon":0},{"id":"2540855550","title":"BUZZ-New Zealand's Rua Bioscience surges on legal resolution with Australia's Cann Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2540855550","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540855550?lang=en_us&edition=fundamental","pubTime":"2025-06-04 08:20","pubTimestamp":1748996454,"startTime":"0","endTime":"0","summary":"BUZZ-New Zealand's Rua Bioscience surges on legal resolutionwith Australia's Cann Group** Shares of Rua Bioscience RUA.NZ rise 7.7% to NZ$0.028, eyeing their strongest trading session since May 21, if gains sustain** Medical cannabis firm reaches settlement with Australian peer Cann Group CAN.AX following legal proceedings initiated by Rua in February 2024** Proceedings on damage claims for breach of contractual rights to exclusively sell Cann's products in Australia** Cann shares rise as much as 7.1% to A$0.02 in early hours of trade** Rua adds both cos have executed new supply agreements to support their respective operations in New Zealand and Australia** More than 129,000 shares change hands, 1.9 times its 30-day avg volume** Rua down 3.5% YTD, including current session's moves","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nL6N3S700S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7502","BK7096","BK7508","CAN.AU"],"gpt_icon":1},{"id":"2540882170","title":"Mayne Pharma Group Ltd - Board Does Not Consider Material Adverse Change","url":"https://stock-news.laohu8.com/highlight/detail?id=2540882170","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540882170?lang=en_us&edition=fundamental","pubTime":"2025-06-04 07:20","pubTimestamp":1748992826,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nFWN3S60FY:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","MYX.AU","BK7508"],"gpt_icon":0},{"id":"2540219088","title":"Mayne Pharma Group Ltd - Committed to Scheme Completion","url":"https://stock-news.laohu8.com/highlight/detail?id=2540219088","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540219088?lang=en_us&edition=fundamental","pubTime":"2025-06-04 07:20","pubTimestamp":1748992826,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nFWN3S60FY:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7096","MYX.AU"],"gpt_icon":0},{"id":"2540108821","title":"Mayne Pharma Group Ltd -  10 Business Day Consultation Period Asserted by Cosette in Cosette Notice Has NOW Expired","url":"https://stock-news.laohu8.com/highlight/detail?id=2540108821","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540108821?lang=en_us&edition=fundamental","pubTime":"2025-06-04 07:20","pubTimestamp":1748992826,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nFWN3S60FY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","BK7508","MYX.AU"],"gpt_icon":0},{"id":"2540741702","title":"BRIEF-Rua Bioscience Says Co & Cann Reach Resolution In Legal Proceedings","url":"https://stock-news.laohu8.com/highlight/detail?id=2540741702","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540741702?lang=en_us&edition=fundamental","pubTime":"2025-06-04 04:49","pubTimestamp":1748983798,"startTime":"0","endTime":"0","summary":"BRIEF-Rua Bioscience Says Co & Cann Reach Resolution In Legal ProceedingsJune 4  - Rua Bioscience Ltd RUA.NZ:RUA AND CANN REACH POSITIVE RESOLUTION IN LEGAL PROCEEDINGSCO, CANN EXECUTED NEW SUPPLY DEALS TO SUPPORT RESPECTIVE OPERATIONS IN AUNZ MEDICINAL CANNABIS MARKETSFurther company coverage: RUA.NZ ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nFWN3S607U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAN.AU","BK7508","BK7096","BK7502"],"gpt_icon":0},{"id":"2540742003","title":"Immuron Ltd-Proposed Issue of Securities - Imc","url":"https://stock-news.laohu8.com/highlight/detail?id=2540742003","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540742003?lang=en_us&edition=fundamental","pubTime":"2025-06-03 14:39","pubTimestamp":1748932770,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nTUE1VLS0V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","IMC.AU"],"gpt_icon":0},{"id":"2540451857","title":"ASX Midday Sector Update: Energy Stocks Rise, Healthcare Struggles","url":"https://stock-news.laohu8.com/highlight/detail?id=2540451857","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540451857?lang=en_us&edition=fundamental","pubTime":"2025-06-03 11:33","pubTimestamp":1748921586,"startTime":"0","endTime":"0","summary":"The energy sector advanced 0.6% at midday Tuesday.Australian stocks tracked Wall Street higher amid reports that the White House is pushing for a call between US President Donald Trump and Chinese President Xi Jinping.Woodside Energy Group  lodged a request for international arbitration with the World Bank's International Center for Settlement of Investment Disputes  against the Republic of Senegal. The request filed on May 30 identified Senegal's Ministry of Petroleum and Energy as the respondent but did not provide further details. The company operates the Sangomar oil and gas field in Senegal and holds an 82% stake in the project.On the flip side, the healthcare sector fell 0.7%.Paradigm Biopharmaceuticals  activated a clinical site in Australia, with the first patient providing consent to participate in the phase three trial testing injectable pentosan polysulfate sodium for knee osteoarthritis pain. The trial also includes 48 US sites preparing for activation, with first patient c","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HCSG","BK7142","BK7067","BK4137","PAR.AU","BK7508","WDS.AU"],"gpt_icon":0},{"id":"2540714191","title":"Paradigm Biopharmaceuticals Activates First Australian Site for Phase Three Osteoarthritis Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2540714191","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540714191?lang=en_us&edition=fundamental","pubTime":"2025-06-03 08:48","pubTimestamp":1748911680,"startTime":"0","endTime":"0","summary":"Paradigm Biopharmaceuticals  has activated a clinical site in Australia, with the first patient providing consent to participate in the phase three trial testing injectable pentosan polysulfate sodium  for knee osteoarthritis pain, according to a Tuesday filing with the Australian bourse.The trial also includes 48 US sites preparing for activation, with first patient consent and dosing expected next quarter, the filing said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XJO.AU","XAO.AU","BK7067","PAR.AU","XKO.AU","BK7508"],"gpt_icon":0},{"id":"2540764658","title":"Opthea Limited Trading Halted on ASX and Nasdaq Amid Financial Uncertainty and Ongoing Negotiations","url":"https://stock-news.laohu8.com/highlight/detail?id=2540764658","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540764658?lang=en_us&edition=fundamental","pubTime":"2025-06-02 18:06","pubTimestamp":1748858796,"startTime":"0","endTime":"0","summary":"Opthea Limited has announced a trading suspension for its listed securities on the Australian Securities Exchange  under ASX Listing Rule 17.3, as well as a halt on its American Depositary Shares on Nasdaq. The suspension is in place until Opthea can provide a market announcement clarifying its financial position amid ongoing negotiations with Development Funding Agreement investors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Opthea Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 02, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nNDL1JRgd0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OPT.AU","BK7067","BK7508"],"gpt_icon":0},{"id":"2540137768","title":"Australian Shares Flat as US-China Trade Tensions Escalate; Brickworks, Soul Pattinson Agree to Merge","url":"https://stock-news.laohu8.com/highlight/detail?id=2540137768","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540137768?lang=en_us&edition=fundamental","pubTime":"2025-06-02 14:59","pubTimestamp":1748847598,"startTime":"0","endTime":"0","summary":"Australian shares ended flat with a slight negative bias on Monday, as Beijing and Washington accused each other of violating recent trade agreements.The S&P/ASX 200 Index was little changed to close ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7105","BK7511","XAO.AU","BK7044","BK7067","BK7501","BK7083","BK7135","BK4080","XJO.AU","ADC","BK7040","COL.AU","OPT.AU","XKO.AU","BK7082","NAB.AU","SOL.AU","BK7508","BK4231","BKW.AU","WBC.AU"],"gpt_icon":0},{"id":"2540751569","title":"Mayne Pharma Group Unit Seeks Over $11.5 Million in Damages in US Court Complaint Against TherapeuticsMD","url":"https://stock-news.laohu8.com/highlight/detail?id=2540751569","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540751569?lang=en_us&edition=fundamental","pubTime":"2025-06-02 10:51","pubTimestamp":1748832718,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group  said that one of its US subsidiaries, Mayne Pharma LLC, filed a complaint in the United States District Court for the District of Delaware against TherapeuticsMD, seeking over $11.5 million in damages incurred as a result of alleged misrepresentations about assets sold by the firm, according to a Monday Australian bourse filing.The complaint made claims against TherapeuticsMD for alleged breach of contract and fraud, alleging that the firm concealed information about certain commercialization assets it sold to Mayne Pharma on Dec. 4, 2022.The complaint is related to the legal proceeding brought by TherapeuticsMD earlier, alleging breach of contract, fraudulent inducement, and unjust enrichment related to the 2022 transaction agreement between both firms.Mayne Pharma filed a motion to dismiss TherapeuticsMD's proceeding in its entirety.The unit denies any and all allegations of wrongdoing and believes TherapeuticsMD's proceeding to be without merit.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","TXMD","BK7096","BK4007","MYX.AU"],"gpt_icon":0},{"id":"2540759959","title":"My top 3 picks in the ASX 20 in June","url":"https://stock-news.laohu8.com/highlight/detail?id=2540759959","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540759959?lang=en_us&edition=fundamental","pubTime":"2025-06-02 09:59","pubTimestamp":1748829541,"startTime":"0","endTime":"0","summary":"The ASX 20 is home to many top-quality stocks. After all, you don't make it to the exclusive club that is the largest 20 public companies listed on our stock market without doing something right. Sayi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/06/02/my-top-3-picks-in-the-asx-20-in-june/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["XAO.AU","CBA.AU","XKO.AU","CSL.AU","WBC.AU","BK7135","BK7067","TCL.AU","BK7511","XJO.AU","ANZ.AU","BK7090","BK7508","BK7501","NAB.AU"],"gpt_icon":0},{"id":"2540490755","title":"Opthea Says 'Going Concern' Uncertainty Remains as Talks With Development Funding Agreement Investors Continue","url":"https://stock-news.laohu8.com/highlight/detail?id=2540490755","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540490755?lang=en_us&edition=fundamental","pubTime":"2025-06-02 09:00","pubTimestamp":1748826006,"startTime":"0","endTime":"0","summary":"Opthea  said there remains material uncertainty as to its ability to continue as a \"going concern\" as it continues to be in active negotiations with its development funding agreement investors, according to a Monday Australian bourse filing.The management plans to hold an investor call to discuss the phase three trial results and the next steps of the firm once the negotiations with the investors have been concluded.In the same filing, the company said Julia Haller, Susan Orr, Quinton Oswald, and Anshul Thakral resigned as directors, effective Monday, to streamline the governance in the wake of negative phase three trial results and a 65% reduction in workforce.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","OPT.AU","BK4139","BK4211","BK7067","OPT","ISBC"],"gpt_icon":0},{"id":"2540755907","title":"BRIEF-Mayne Pharma Posts Update On US Legal Proceeding With Therapeuticsmd Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2540755907","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540755907?lang=en_us&edition=fundamental","pubTime":"2025-06-02 08:57","pubTimestamp":1748825879,"startTime":"0","endTime":"0","summary":"BRIEF-Mayne Pharma Posts Update On US Legal Proceeding With Therapeuticsmd IncJune 2  - Mayne Pharma Group Ltd MYX.AX:UPDATE ON US LEGAL PROCEEDING WITH THERAPEUTICSMD INC-MYX.AXFILES COMPLAINT AGAINST THERAPEUTICSMD IN US COURTALLEGES TXMD CONCEALED INFORMATION ABOUT ASSETSSEEKS OVER $11.5 MILLION IN DAMAGES FROM TXMDSEEKS OVER US$11.5 MILLION IN DAMAGES FROM TXMDFurther company coverage: MYX.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nFWN3S303M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","MYX.AU","BK7508"],"gpt_icon":0},{"id":"2540758744","title":"Mayne Pharma Group Ltd - Files Complaint Against TherapeuticsMD in US Court","url":"https://stock-news.laohu8.com/highlight/detail?id=2540758744","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540758744?lang=en_us&edition=fundamental","pubTime":"2025-06-02 07:18","pubTimestamp":1748819916,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250601:nFWN3S303M:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MYX.AU","BK7508","BK7096"],"gpt_icon":0},{"id":"2540758726","title":"Mayne Pharma Group Ltd - Seeks Over $11.5 Mln in Damages From Txmd","url":"https://stock-news.laohu8.com/highlight/detail?id=2540758726","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540758726?lang=en_us&edition=fundamental","pubTime":"2025-06-02 07:18","pubTimestamp":1748819916,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250601:nFWN3S303M:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7096","MYX.AU"],"gpt_icon":0},{"id":"2540728758","title":"Update on US Legal Proceeding With TherapeuticsMD Inc-Myx.ax","url":"https://stock-news.laohu8.com/highlight/detail?id=2540728758","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540728758?lang=en_us&edition=fundamental","pubTime":"2025-06-02 07:18","pubTimestamp":1748819916,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250601:nFWN3S303M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","MYX.AU","BK7096"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":74,"code":"91000000","status":"200"}]}}